Home  About us  Contact
 

Related Macular Degeneration (relate + macular_degeneration)

Distribution by Scientific Domains
Medical Sciences100%

Kinds of Related Macular Degeneration

  • age relate macular degeneration
    		•

    Selected Abstracts

    Diode laser photocoagulation of choroidal neovascularization associated with retinal pigment epithelial detachment

    ACTA OPHTHALMOLOGICA, Issue 1 2001
    Francisco Gomez-Ulla
    ABSTRACT. Aims/Background: Association of choroidal neovascularization with pigment epithelial detachment is not an uncommon feature. Since this condition usually has a poor visual outcome, new treatments should be developed. Methods: We studied the anatomical and visual results of 11 eyes with this association as a manifestation of an Exudative Age Related Macular Degeneration which were treated with diode laser photocoagulation guided by indocyanine green angiography. The average follow up time was 25.5 months (from 12 to 48 months). Results: Complete closure with complete resolution of the exudates and flattening of the detachment was observed in five eyes (45%). Visual acuity in the final examination improved or remained stable in 6 cases (55%). Conclusion: These results indicate that diode laser photocoagulation guided by indocyanine green angiography is at least as effective as conventional lasers with shorter wavelengths for treatment of vascularized pigment epithelial detachments in Age Related Macular Degeneration. [source]

    Low vision service delivery: an audit of newly developed outreach clinics in Northern Ireland,

    OPHTHALMIC AND PHYSIOLOGICAL OPTICS, Issue 4 2004
    J. Lindsay
    Abstract Recent publications recommend that low vision services are multi-professional; easily accessible; freely available to all those with visual impairment; monitored by professional and patient groups, and responsive to user feedback. These standards were applied when developing low vision outreach services in Northern Ireland in 1999/2000. Results are reported of the complete clinical audit cycle, coupled with a patient satisfaction telephone questionnaire, which was used to evaluate the service. Of the 48 patients randomly selected from the list of clinic attendees, 28 (58%) were female, 27 (56%) over 80 years of age and 38 (78%) had a primary ocular diagnosis of age related macular degeneration (AMD). Of the 46 low vision aids issued at patients' first appointments, 30 (67%) were illuminated stand magnifiers and 29 (63%) had magnification levels of ×5 or less. A total of 46 (96%) patients reported that they had benefited from low vision services. [source]

    1334: Autofluorescence: new tool to follow dry eye AMD?

    ACTA OPHTHALMOLOGICA, Issue 2010
    MN MENKE
    Purpose In the pathophysiolgy of dry (atrophic) age related macular degeneration (AMD) aging of the retinal pigment epithelium (RPE) plays a key role. Accumulation of lipofuscin granules in the RPE cells represents a common downstream pathogenetic pathway in AMD. Lipofuscin is derived from chemically modified residues of incompletely digested photoreceptor outer segment discs. Detection of lipofuscin in vivo is possible by using fundus autofluorescence (FAF) imaging. The clinical application and possible implications of autofluorescence imaging in dry AMD will be discussed. Methods When stimulated with light in the blue to green range, lipofuscin granules emit a characteristic yellow fluorescence. FAF imaging using a scanning laser ophthalmoscope allows visualization of the topographic distribution of lipofuscin over large retinal areas. Examples of FAF images will be presented to demonstrate various FAF patterns and to discuss the clinical significance of these findings. Results In areas of geographic atrophy FAF images show very low autofluorescence intensity. This is due to the loss of RPE cells including the lipofuscin granules. In the junctional zone between atrophic and normal retina, levels of increased autofluorescence intensity may occur due to excessive accumulation of lipofuscin in the RPE cells. Longitudinal observations further suggest that the extension of the total area with increased autofluorescence intensity surrounding atrophy at baseline has a strong positive correlation with atrophy progression rate over time. Conclusion FAF imaging is an important diagnostic tool to follow the progression of dry AMD and other degenerative macular diseases and should always be considered in cases were the status of the RPE is unknown. [source]

    4233: Outcomes of the Boston Keratoprosthesis Type II

    ACTA OPHTHALMOLOGICA, Issue 2010
    J CHODOSH
    Purpose To report the long term outcomes of Boston keratoprosthesis type II implantation in the management of severe ocular surface disease and corneal blindness. Methods A retrospective review of medical records of patients after Boston keratoprosthesis type II implantation at the Massachusetts Eye and Ear Infirmary from January, 1, 2000 through December 31, 2009. Main outcome measures included visual acuity, device retention, and postoperative complications. Results A total of 29 eyes of 26 patients received a Boston keratoprosthesis type II during the study period. Operated patients had corneal blindness due to mucous membrane pemphigoid (51.7%), Stevens Johnson syndrome/toxic epidermal necrolysis (41.4%), or other ocular surface disease (6.9%). Visual acuity after surgery improved to at least 20/200 in 23 eyes (79.3%), and to 20/30 or better in 10 eyes (34.5%). In patients with at least 1 year of follow-up (n=21), visual acuity of 20/200 or better was maintained in 14 eyes (66.7%). Of these 14 eyes, 6 eyes (42.9%) retained visual acuity of 20/200 or better for more than 5 years. Overall, visual acuity of 20/200 or better was maintained for at least 5 years in 6 of 23 eyes (26.0%). Eyes that failed to improve to 20/200 or lost vision during follow-up were found to have end stage glaucoma, previous retinal detachment, or age related macular degeneration. Of the total of 29 eyes, 17 devices (58.6%) were retained without extrusion or replacement during a total follow-up time of 107.9 person-years. Conclusion The Boston keratoprosthesis type II is a viable option for corneal blindness from severe autoimmune ocular surface diseases. Complications require prompt recognition and management to promote retention of the device and preservation of vision. [source]

    Ocular rigidity in living human eyes in health and disease

    ACTA OPHTHALMOLOGICA, Issue 2009
    IG PALLIKARIS
    Purpose It is known that the balance between aqueous humor secretion and outflow rate controls the steady - state average intraocular pressure (IOP). It has been also early identified that blood circulation results to IOP fluctuations practically synchronous to cardiac function. IOP is the primary mechanical load to several ocular structures including the optical nerve head. Methods In-vivo intraoperative measurement of these quantities as well as secretion/outflow coefficients in humans allowed us to quantify ocular rigidity, IOP and its fluctuations (and pulsatile blood flow) in a series of physiological and pathological eyes. Ocular rigidity, outflow facility and pulsatile ocular blood flow were measured intraoperatively in a cohort of 63 patients undergoing cataract surgery. Measurements were also performed in a series of age related macular degeneration (AMD) patients. Results The eye, is a living structure under a continuously varying mechanical load that is strongly related to ocular haemodynamics. Ocular rigidity ranged from 0.0122 to 0.0343 (mean 0.0208),l-1. Outflow facility coefficient (derived from pressure decay curves) was 0.33 (sd 0.15),l/min/mmHg. Pulsatile ocular blood flow exhibited a strong negative correlation to IOP in all subjects. The ocular rigidity coefficient was higher in wet AMD patients compared to patients with dry AMD and healthy controls. Conclusion There are indications that this mechanical load, associated also to ocular rigidity, can not only inter-modulate blood flow but also have a long-term effect on other structures in the eye. Understanding the role of these parameters may contribute to the understanding of ocular disease. [source]

    Age related macular degeneration

    ACTA OPHTHALMOLOGICA, Issue 2009
    M VOIGT
    [source]

    High-definition Fourier domain OCT: non-invasive assessment of BRB changes

    ACTA OPHTHALMOLOGICA, Issue 2009
    R BERNARDES
    Purpose To demonstrate the possibility of using a non-invasive imaging technique, the high-definition spectral domain optical coherence tomography, as a surrogate detector of blood-retinal barrier (BRB) breakdown. Methods Healthy volunteers and diabetic patients with diabetic retinopathy, age- related macular degeneration, choroidal neo-vascularisation and cystoid macular edema, underwent optical coherence tomography by Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA, USA). Profiles of reflectivity distribution between the inner-limiting membrane and the retinal pigment epithelium were built, normalized, aligned and compared. Patients underwent retinal leakage analyzer (RLA) to identify areas of retinal fluorescein leakage into the vitreous as areas of blood-retinal barrier breakdown. Results The comparison between healthy volunteers' and patients' reflectivity distribution demonstrates these profiles differ. Moreover, when comparing reflectivity distribution within the same eye between areas of leakage and areas of non-leakage, the sum of the squared differences is over one decade relatively to the comparison between two similar areas (leakage/leakage or non-leakage/non-leakage). Conclusion These findings suggest that high-definition OCT may be useful in identifying areas of retinal leakage/BRB breakdown and therefore to be used as surrogate for fluorescein angiography and retinal leakage analyzer. [source]

    The role of lox and LOXL2 in inflammation and fibrosis in a laser induced mouse model

    ACTA OPHTHALMOLOGICA, Issue 2009
    S VAN DE VEIRE
    Purpose Lysyl oxidase (LOX) and lysyl oxidase-like protein 2 (LOXL2) are involved in the cross-linking of collagen and elastin in the extracellular space. The aim of this study was to investigate the expression LOX and LOXL2 in the eye (choroidea and retina) after laser-induced chroidal neovascularization (CNV). We also want to check the anti-angiogenic, anti-inflammatory and anti-fibrotic efficacy of anti-LOX and anti-LOXL2 antibody in a mouse model of age related macular degeneration (ARMD). Methods CNV will be induced in 8 to 10 weeks old C75Bl/6 mice, by placing 3 laser spots at 9, 12 and 3 o'clock position (50µm, 0.05 s and 400mW). Two daily injection with LOX(L) antibodies or control solution (PBS-Tween 20%) will be given intraperitoneally from day 0 after lasering until day 34. Immediately after death, both eyes will be enucleated. One eye will be used to check RNA-expression of LOX and LOXL. The other eye will be used to perform different immunohistochemical stainings (HE, Sirius Red, Trichrome, CD31, CD45 and LOX(L)). Results Preliminary results showed a significant increase of LOX and LOXL2 in the choroid and retina after lasering compared to control. Conclusion ARMD remains the most common cause of irreversible vision loss in people aged 50 years and older, due to (sub-)retinal neovascularisation and scarring. It is already known that LOX and LOXL are playing a role in the cross linking of collagen and elastin, leading to an increase of fibrosis, and there is growing evidence that these molecules also play a role in neovascularisation. Therefore, a therapeutic potential of anti-LOX and/or anti-LOXL therapy can open new perspectives to treat CNV. [source]